Medtronic
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
29.26 | 114.26 | -74.39% | 33.47 | -12.57% |
| P/S |
|
3.32 | 4.1 | -19% |
|
|
| P/BV |
|
2.13 | 9.02 | -76.36% |
|
|
| P/FCF |
|
20.87 | 44.54 | -53.14% |
|
|
| Ev/Ebitda |
|
16.13 | 17.72 | -8.97% |
|
|
| Ev/S |
|
4.09 | 4.4 | -7.17% |
|
|
| Ev/FCF |
|
25.45 | 54.7 | -53.48% |
|
|
| E/P |
|
0.0339 | 0.2136 | -84.13% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
25.35 | 21.49 | 17.96% | 26.86 | -5.65% |
| ROE |
|
7.23 | -82.41 | -108.77% |
|
|
| ROA |
|
4.06 | 6.75 | -39.81% |
|
|
| ROIC |
|
9.79 | 15.68 | -37.56% |
|
|
| ROS |
|
11.36 | 10.29 | 10.41% |
|
|
| ROCE |
|
11.02 | 55.35 | -80.09% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
4/10
|
3.18 | 0.9571 | 231.77% | 3.02 | +5.31% |
| Nеt Debt/Ebitda |
|
3.02 | 2.1 | 44.06% |
|
|
| Debt/Ratio |
|
0.2895 | 0.2655 | 9.04% |
|
|
| Debt/Equity |
|
3.94 | 4.81 | -18.1% |
|
|
| Debt/Net Income |
|
7.09 | 35.64 | -80.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
8.35/10
|
3.34 | 1.27 | 163.22% | 2.91 | +14.71% |
| Number of years of dividend growth |
|
10 | 6.35 | 57.5% | ||
| DSI |
|
1 | 0.7501 | 33.31% |
|
|
| Average dividend growth |
|
5.68 | -0.99 | -673.9% |
|
|
| Average percentage for 5 years |
|
2.91 | 1.27 | 128.7% |
|
|
| Average percentage for payments |
|
37.95 | 77.77 | -51.21% |
|
|
| Difference from average difference in sector |
|
2.07 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
2/10
|
11.95 | 214.83 | -94.44% | ||
| Growth impulse Ebitda in 5 years |
|
-0.449 | 253.48 | -100.18% | ||
| Growth impulse Net Income in 5 years |
|
-23.26 | 270.34 | -108.6% | ||
| Growth impulse FCF in 5 years |
|
-13.62 | 183.09 | -107.44% | ||
| Growth impulse EPS in 5 years |
|
-21.94 | 149.95 | -114.63% |
IP Score
4.77/10
